Cardio3 BioSciences Secures Additional EUR 3.1 Million in Non-dilutive Funding ... MarketWatch (press release) The Walloon region has played a significant role through the history of Cardio3 BioSciences helping to bring us to the point where our core revolutionary technology, C-Cure, for the treatment of heart failure, has passed through successful completion ... |
